Literature DB >> 5421723

Penicillamine in rheumatoid arthritis.

J Zuckner, R H Ramsey, R W Dorner, G E Gantner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5421723     DOI: 10.1002/art.1780130205

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  8 in total

1.  The influence of drug therapy on serum immunoglobulin profiles in rheumatoid arthritis.

Authors:  A J Swannell; J Watkins
Journal:  Proc R Soc Med       Date:  1977

2.  The antiinflammatory action of some compounds with antioxidant properties.

Authors:  L Levy
Journal:  Inflammation       Date:  1976-12       Impact factor: 4.092

3.  Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor.

Authors:  R Bluestone; L S Goldberg
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

4.  Penicillamine in the treatment of rheumatoid arthritis.

Authors:  A V Camp
Journal:  Proc R Soc Med       Date:  1977-02

5.  Effects of D-penicillamine on growth and cell cycle kinetics of cultured rabbit articular chondrocytes.

Authors:  P Jaffray; X Ronot; M Adolphe; J Fontagne; P Lechat
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

6.  Antirheumatic drugs: clinical pharmacological and therapeutic aspects.

Authors:  C J Smyth; J F Bravo
Journal:  Drugs       Date:  1975       Impact factor: 9.546

7.  Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

8.  Historical perspectives on penicillamine.

Authors:  L Fernandes; H Berry; E Hamilton
Journal:  J R Coll Physicians Lond       Date:  1980-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.